Advertisement
News
Subscribe to Drug Discovery & Development News

The Lead

WHO: Global Vaccination Records 'Off-Track'

April 23, 2015 | Comments

Progress towards global vaccination targets for 2015 is far off-track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Grants Priority Review for AbbVie's Hepatitis C Treatment

April 24, 2015 12:16 pm | Comments

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV).  Read more...

TOPICS:

Fragile X Syndrome: Building a Case for an Alternative Treatment Strategy

April 24, 2015 12:01 pm | by Emory Health Sciences | Comments

New research strengthens a potential strategy for treating fragile X syndrome, the most common inherited form of intellectual disability. Read more...

TOPICS:

Hope for an Effective Malaria Therapy with Just One Tablet

April 24, 2015 8:54 am | by Medical University of Vienna | Comments

Approximately 584,000 people worldwide die of malaria each year. Read more...

TOPICS:
Advertisement

Manchester Joins European Consortium to Develop Liquid Biopsies

April 24, 2015 8:47 am | by University of Manchester | Comments

An international project to validate blood-based biomarkers for cancer has added a new member. Read more...

TOPICS:

Protein Links Point to Future Alzheimer's Treatments

April 24, 2015 8:29 am | by University of Cambridge | Comments

Researchers have identified how proteins that play a key role in Alzheimer’s disease are linked in a pathway that controls its progression. Read more....

TOPICS:

FDA Grants Priority Review for Boehringer Ingelheim's Idarucizumab

April 23, 2015 2:06 pm | Comments

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for idarucizumab. Read more...

TOPICS:

FDA Accepts Filing of Bayer's MS Treatment

April 23, 2015 2:03 pm | Comments

Bayer is pleased to announce today that the U.S. Food and Drug Administration (FDA) has accepted the filing for Bayer's supplemental Biologics License Application (sBLA) for Betaconnect (proposed name), another delivery option for Betaseron (interferon beta-1b), a treatment for relapsing-remitting multiple sclerosis. 

TOPICS:

Finding Points to a Cause of Chronic Lung Disease

April 23, 2015 1:58 pm | by Washington University in St. Louis | Comments

Scientists have long suspected that respiratory viruses — the sort that cause common colds or bronchitis — play a critical role in the long-term development of chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Read more...

TOPICS:
Advertisement

Majority of Lung Cancer Treatment Decisions Not Guided by Genetics: Survey

April 23, 2015 1:47 pm | Comments

Despite the majority of newly diagnosed advanced non-small cell lung cancer (NSCLC) patients being tested for genetic mutations, a gap still exists for providing a personalized treatment plan for patients based on their cancer type and mutation subtype, according to a new international survey. Read more...

TOPICS:

CDC Using New Technology to Track Listeria Illnesses

April 23, 2015 1:41 pm | by Mary Clare Jalonick, Associated Press | Comments

The government is relying on some new technology - as well as a bit of luck - to track an outbreak of life-threatening listeria linked to Blue Bell ice cream products. Read more...

TOPICS:

Abbvie Raises Outlook as Humira Again Delivers Earnings Beat

April 23, 2015 1:36 pm | by Matthew Perrone, AP Health Writer | Comments

Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted results on continued growth of its blockbuster anti-inflammatory drug Humira. Read more...

TOPICS:

Roche Sales Up 3 Percent Amid Demand for Breast Cancer Drugs

April 23, 2015 9:15 am | by The Associated Press | Comments

Breast cancer drugs such as Herceptin as well as new uses for multi-cancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by 3 percent during the first quarter. Read more...

TOPICS:

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 9:11 am | by The Associated Press | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies. Read more...

TOPICS:

Human Clinical Trials Planned for New Anti-Cancer Compound

April 23, 2015 8:55 am | by University of Auckland | Comments

Researchers developed a new anti-cancer compound that will advance to human phase two clinical trials. Read more...

TOPICS:

Alcoholic Hepatitis Treatments Fail to Keep Patients Alive

April 23, 2015 8:51 am | by Imperial College London | Comments

The main drugs used to treat alcoholic hepatitis are not effective at increasing patients' survival. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading